Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 384 participants.
Also called NCT07744035
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 384 participants
- Sponsor
- Registry
-
NCT07744035
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07744035. Randomized; no masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
- Acronym
- ATTRACTION
- Condition
- Atrial Functional Mitral Regurgitation
- Condition
- Atrial Fibrillation (AF)
- Intervention (Device)
- Transcatheter edge to edge repair
- Intervention (Procedure)
- Catheter ablation
- Lead sponsor
- Mao Chen
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct07744035- Content hash
f624adb7bcba7711cdc4404094a09259bf05e32be04e14e611269f566eacb408